News

CEBINA reports potency of azelastine against emerging dominant variants of SARS-CoV-2 in laboratory testing

CEBINA announced that azelastine is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus.

Read more
To endure oxidative conditions, RTCB (bottom half) co-evolved with the dedicated protector PYROXD1 (depicted holding a shield). PYROXD1 utilizes the flavin molecule (represented in orange) and the cofactor NAD(P)+ (red) to shield RTCB from oxygen and reactive oxygen species (air bubbles), which would together with copper ions (violet balls) cause RTCB inactivation, abrogating tRNA biogenesis and stress response. (c) Tanja Asanovic

A protein bodyguard – private security in the defense against oxidation

Oxidative stress is a biochemical condition in which the levels of oxidant molecules exceed the level of reductants (also known as anti-oxidants) in…

Read more

Two ERC Advanced Grants for research at Vienna BioCenter

Double-success for scientists at the Vienna BioCenter: as the European Research Council (ERC) announced today, it will support the research of Daniel…

Read more

Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

Valneva announced it has initiated a pivotal Phase 3 clinical trial for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

Read more

Read more
Single nuclei stained with DAPI (cyan) and recombinase RAD-51 (red). In top-3 mutant RAD-51 foci were much more abundant and coalesced into stretches, which is never observed in the wt. (c) Taken from Figure 1 Dello Stritto et al., JCB 2021.

Keeping oocytes fit with Topoisomerase-3

During germ cell development faulty meiocytes are eliminated via apoptosis, a programmed cell death to ensure that only healthy gametes are produced.…

Read more

Flowering rooted in embryonic gene-regulation

Researchers at GMI – Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences – and the John Innes Centre, Norwich,…

Read more

From Bench to Bedside - Molecular Pathogenesis to Precision Medicine

The Medical University of Vienna in cooperation with the University of Vienna has launched a new Master´s Program in Molecular Precision Medicine…

Read more

Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and Initiates Antibody Persistence Trial

Valneva today announced that it has completed recruitment for the pivotal Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553.

Th…

Read more

A refined axolotl genome assembly sheds light on basic cellular processes

After the first assembly of an axolotl genome was published in 2018, the lab of Elly Tanaka teamed up with scientists at the University of Kentucky to…

Read more

Brain organoids uncover various mechanisms of virus-induced microcephaly

Researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – demonstrate that different viruses can lead to brain…

Read more

Lockdown for genome parasites

Researchers at GMI – Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences – uncover an ingenious mechanism by which…

Read more

Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

Valneva announced positive data for Part A of the Phase 1/2 clinical trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Based…

Read more